New Jersey cell therapy startup venture Celularity, founded by a cell therapy pioneer Bob Hariri, is among the first ventures to recognize the human placenta as an untapped resource for innovation—and, in fact, the foundation of their science is built on innovations...
The German Federal Ministry of Education and Research (BMBF), has transferred €2.45m to a research collaborative known as LeukoSyStem to “get to the root of the problem” of leukemia. With an emphasis on stem cell research and “the starting point of leukemia,” the...
In a notable partnership, Switzerland-based Lonza inked a partnership with leading research institutes and academic medical centers including Stanford University School of Medicine, Fred Hutchinson Cancer Research Center and Parker Institute for Cancer Immunotherapy...
Nationwide Children’s Hospital (NCH), a global hub for advanced gene therapy discovery, has submitted a proposal to the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services (HHS) to pursue possible treatments...
University of Pittsburgh and University of Delaware researchers received funding for research covering innovative therapies targeting pulmonary fibrosis (FB) to Gene delivery to or editing Hematopoietic (blood) Stem and Progenitor Cells (HSPCs). Two clinical...
Duke University, through the Immune Tolerance Network, is offering a multicenter, Phase III interventional clinical trial examining the efficacy of autologous hematopoietic stem cell transplantation, an emerging therapy for patients with active, treatment-resistant,...
